Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium
- PMID: 17018785
- DOI: 10.1093/jnci/djj374
Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium
Erratum in
- J Natl Cancer Inst. 2007 May 7;99(5):411
Abstract
Background: The Breast Cancer Association Consortium (BCAC) is an international collaboration that was established to provide large sample sizes for examining genetic associations. We conducted combined analyses on all single-nucleotide polymorphisms (SNPs) whose associations with breast cancer have been investigated by at least three participating groups.
Methods: Data from up to 12 studies were pooled for each SNP (ADH1C I350V, AURKA F31I, BRCA2 N372H, CASP8 D302H, ERCC2 D312N, IGFBP3 -202 c>a, LIG4 D501D, PGR V660L, SOD2 V16A, TGFB1 L10P, TP53 R72P, XRCC1 R399Q, XRCC2 R188H, XRCC3 T241M, XRCC3 5' UTR, and XRCC3 IVS7-14). Genotype frequencies in case and control subjects were compared, and genotype-specific odds ratios for the risk of breast cancer in heterozygotes and homozygotes for the rare allele compared with homozygotes for the common allele were estimated with logistic regression. Statistical tests were two-sided.
Results: The total number of subjects for analysis of each SNP ranged from 12,013 to 31,595. For five SNPs--CASP8 D302H, IGFBP3 -202 c>a, PGR V660L, SOD2 V16A, and TGFB1 L10P--the associations with breast cancer were of borderline statistical significance (P = .016, .060, .047, .056, and .0088 respectively). The remaining 11 SNPs were not associated with breast cancer risk; genotype-specific odds ratios were close to unity. There was some evidence for between-study heterogeneity (P<.05) for four of the 11 SNPs (ADH1C I350V, ERCC2 D312N, XRCC1 R399Q, and XRCC3 IVS5-14).
Conclusion: Pooling data within a large consortium has helped to clarify associations of SNPs with breast cancer. In the future, consortia such as the BCAC will be important in the analysis of rare polymorphisms and gene x gene or gene x environment interactions, for which individual studies have low power to identify associations, and in the validation of associations identified from genome-wide association studies.
Comment in
-
Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects.J Natl Cancer Inst. 2006 Oct 4;98(19):1350-3. doi: 10.1093/jnci/djj392. J Natl Cancer Inst. 2006. PMID: 17018776 No abstract available.
-
Re: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.J Natl Cancer Inst. 2007 Mar 21;99(6):487-8; author reply 488-9. doi: 10.1093/jnci/djk098. J Natl Cancer Inst. 2007. PMID: 17374838 No abstract available.
-
Re: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.J Natl Cancer Inst. 2007 Mar 21;99(6):487; author reply 488-9. doi: 10.1093/jnci/djk097. J Natl Cancer Inst. 2007. PMID: 17374839 No abstract available.
Similar articles
-
A common coding variant in CASP8 is associated with breast cancer risk.Nat Genet. 2007 Mar;39(3):352-8. doi: 10.1038/ng1981. Epub 2007 Feb 11. Nat Genet. 2007. PMID: 17293864
-
Impact of Interaction between Single Nucleotide Polymorphism of XRCC1, XRCC2, XRCC3 with Tumor Suppressor Tp53 Gene Increases Risk of Breast Cancer: A Hospital Based Case-Control Study.Asian Pac J Cancer Prev. 2023 Sep 1;24(9):3065-3075. doi: 10.31557/APJCP.2023.24.9.3065. Asian Pac J Cancer Prev. 2023. PMID: 37774058 Free PMC article.
-
Consortium analysis of 7 candidate SNPs for ovarian cancer.Int J Cancer. 2008 Jul 15;123(2):380-388. doi: 10.1002/ijc.23448. Int J Cancer. 2008. PMID: 18431743 Free PMC article.
-
Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses.Hum Genet. 2006 May;119(4):376-88. doi: 10.1007/s00439-006-0135-z. Epub 2006 Feb 17. Hum Genet. 2006. PMID: 16485136
-
XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.Breast Cancer Res Treat. 2010 Jul;122(2):489-93. doi: 10.1007/s10549-009-0726-1. Epub 2010 Jan 5. Breast Cancer Res Treat. 2010. PMID: 20049524 Review.
Cited by
-
The association between XRCC3 rs1799794 polymorphism and cancer risk: a meta-analysis of 34 case-control studies.BMC Med Genomics. 2021 Apr 30;14(1):117. doi: 10.1186/s12920-021-00965-4. BMC Med Genomics. 2021. PMID: 33931047 Free PMC article.
-
Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients.Breast Cancer Res. 2007;9(3):R34. doi: 10.1186/bcr1682. Breast Cancer Res. 2007. PMID: 17537232 Free PMC article.
-
Association between common variation in 120 candidate genes and breast cancer risk.PLoS Genet. 2007 Mar 16;3(3):e42. doi: 10.1371/journal.pgen.0030042. Epub 2007 Feb 2. PLoS Genet. 2007. PMID: 17367212 Free PMC article.
-
Mouse modifier genes in mammary tumorigenesis and metastasis.J Mammary Gland Biol Neoplasia. 2008 Sep;13(3):337-42. doi: 10.1007/s10911-008-9089-1. Epub 2008 Jul 26. J Mammary Gland Biol Neoplasia. 2008. PMID: 18661105 Review.
-
An analysis of growth, differentiation and apoptosis genes with risk of renal cancer.PLoS One. 2009 Mar 24;4(3):e4895. doi: 10.1371/journal.pone.0004895. PLoS One. 2009. PMID: 19603096 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous